Table 3 Application of the proposed method to the determination of the studied drugs in spiked human plasma.
Compound | Concentration taken (μg/mL) | Concentration found (μg/mL) | % Found |
|---|---|---|---|
Rosiglitazone | 0.10 | 0.1058 | 105.80 |
0.25 | 0.2398 | 95.92 | |
0.50 | 0.5017 | 100.34 | |
0.75 | 0.7574 | 100.99 | |
1.0 | 0.9964 | 99.64 | |
X' | 100.54 | ||
± SD | ± 3.54 | ||
% RSD | 3.52 | ||
% Error | 1.57 | ||
Glimepiride | 0.10 | 0.1072 | 107.20 |
0.25 | 0.2487 | 99.48 | |
0.50 | 0.4925 | 98.50 | |
0.75 | 0.7440 | 99.20 | |
1.0 | 1.008 | 100.80 | |
X' | 101.04 | ||
± SD | ± 3.55 | ||
% RSD | 3.51 | ||
% Error | 1.57 |